AUPH logo
AUPH

Aurinia Pharmaceuticals Inc

Biotechnology

Aurinia Pharmaceuticals Inc (AUPH) Earnings

Last reported
April 30, 2026
EPS estimate
$0.20
EPS actual
Revenue est.
$78.9M
Revenue actual